Nov 06 2025

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Ohio’s legal marijuana market has rapidly grown into one of the nation’s most robust, with new state data showing over $1.2 billion in total sales since the launch of the adult-use market in August 2024.

Since recreational sales launched in August 2024, adult-use revenue has reached $923,600,777. Combined with $331,622,009 in medical sales over that same period, the total is $1,255,222,786 between the two markets, resulting in $164,535,387 in tax revenue. That figure reflects only the post-launch window; when including earlier medical activity, Ohio has now surpassed $3.18 billion in lifetime marijuana revenue.
Continue reading

Nov 06 2025

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

A laboratory study in the Journal of Drug Delivery Science and Technology finds that while both a commercial vape pen and a CE-marked medical device can generate respirable marijuana aerosols, only the medical device delivered reliably consistent doses.

Researchers at Université Jean Monnet Saint-Étienne compared a medical inhalation device (BIKY Breathe) with a common retail vape pen across four THC formulations. Both platforms generated submicron particles with mass median aerodynamic diameters around 0.9–1.0 μm and a fine-particle fraction of 99–100%, a range that supports deep-lung deposition and rapid systemic uptake.
Continue reading

Nov 05 2025

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

Arkansas’ medical marijuana program continues to expand, with 112,760 patients now registered as of November 1, 2025, according to new figures released by the Department of Health.

The program was established after voters passed the Arkansas Medical Marijuana Amendment (Issue 6) in November 2016. The measure legalized medical marijuana for patients with qualifying conditions and physician approval. Sales officially began in May 2019 when the first dispensary opened in Hot Springs, marking the start of what has become one of the South’s most robust medical markets.
Continue reading

Nov 05 2025

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

New Mexico’s legal marijuana industry generated $47 million in sales during October, bringing the state’s total for 2025 to roughly $475 million.

Of the October total, $36.6 million came from adult-use purchases and $10.4 million from medical sales, according to data from the Cannabis Control Division. Retailers recorded 1.2 million total transactions during the month, including nearly one million recreational sales.
Continue reading

Nov 05 2025

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Curaleaf Holdings reported $320 million in revenue for the third quarter of 2025, up 2% from the previous quarter.

The company’s overseas operations generated $46 million—up 56% year-over-year—helping offset domestic price compression that has challenged the broader marijuana industry.
Continue reading

Nov 05 2025

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Aurora Cannabis Inc. reported fiscal second-quarter 2026 revenue of $90.4 million, an 11% increase year-over-year, driven largely by record global medical marijuana sales.

The Edmonton-based company said medical cannabis net revenue rose 15% to $70.5 million, accounting for 78% of total revenue. International medical revenue grew 22% to $42.7 million, with strong performance in markets including Australia, Germany, Poland, and the United Kingdom. Aurora’s Canadian medical division also posted gains among both insured and self-paying patients.
Continue reading

Nov 05 2025

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Trulieve Cannabis Corp. reported third-quarter revenue of $288 million, with 94% generated from retail operations and a gross margin of 59%, underscoring continued operational strength and cash flow discipline.

The company, which operates 232 dispensaries across the U.S., said it sold more than 12.5 million branded products during the quarter, a 7% increase from the same period last year. Trulieve achieved an adjusted EBITDA of $103 million, or 36% of revenue, while year-to-date free cash flow reached $173 million. Cash on hand at the end of the quarter was $458 million.
Continue reading

Nov 05 2025

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted treatments, according to a new study by researchers from Rangsit University and Mahidol University.

The study was published in the Journal of Cannabis Research and indexed by the U.S. National Library of Medicine.
Continue reading

Nov 05 2025

D.C. Regulators Propose New Rules Restricting Non-Cannabis Sales at Medical Cannabis Retailers

The Alcoholic Beverage and Cannabis Board (ABCA) has announced proposed rule changes that would significantly limit what non-cannabis products medical marijuana retailers can sell or serve in the District of Columbia.

The proposal, adopted unanimously by the Board, attempts to clarify long-standing ambiguities surrounding non-cannabis retail activity while addressing concerns about youth access and community impact.
Continue reading

Nov 04 2025

Mikie Sherrill Wins New Jersey Governor’s Race, Supports Legalizing Home Cannabis Cultivation

Democrat Mikie Sherrill has been elected governor of New Jersey, a victory that could bring major changes to the state’s marijuana laws, particularly around home cultivation.

Sherrill has consistently backed expanding New Jersey’s adult-use marijuana system to allow residents to grow plants at home, something that remains prohibited under current law. Her position marks a sharp contrast with Republican candidate Jack Ciattarelli, who argued against any expansion and supported keeping the state’s strict limits on cultivation and licensing.
Continue reading